DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Diagnostics – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global marketDUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Diagnostics – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering. The global market
Trends Shaping the $5.8 Billion Gastrointestinal Diagnostics (GI) Market, 2025-2030 – Surge in Colon Cancer Screening Programs Worldwide Expands Market for Colonoscopy and Sigmoidoscopy Devices – ResearchAndMarkets.com
Per feedback o dubbi su questo contenuto, contattateci all'indirizzo crypto.news@mexc.com.
DUBLIN–(BUSINESS WIRE)–The “Gastrointestinal Diagnostics – Global Strategic Business Report” has been added to ResearchAndMarkets.com’s offering.
The global market for Gastrointestinal Diagnostics was valued at US$4.9 Billion in 2024 and is projected to reach US$5.8 Billion by 2030, growing at a CAGR of 2.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
The growth in the gastrointestinal diagnostics market is driven by several factors, including the rising incidence of GI disorders, increasing adoption of advanced imaging technologies, and the shift toward non-invasive diagnostic methods. The global burden of colorectal cancer and inflammatory bowel diseases has led to greater demand for early screening and precision diagnostics. Government initiatives promoting colon cancer screening programs and improved healthcare infrastructure have also contributed to market expansion.
Technological advancements, such as AI-assisted endoscopy, liquid biopsy, and microbiome-based diagnostics, are further accelerating market growth. The increasing preference for home-based and point-of-care testing solutions has expanded patient access to GI diagnostics, particularly in underserved regions. Additionally, the expansion of telemedicine and digital health platforms is enabling remote GI consultations and diagnostic assessments. As healthcare providers continue to emphasize early detection and personalized medicine, the gastrointestinal diagnostics market is expected to experience sustained growth, driven by innovation and rising healthcare awareness.
Report Scope
The report analyzes the Gastrointestinal Diagnostics market, presented in terms of market value. The analysis covers the key segments and geographic regions outlined below.
- Segments: Test (Endoscopy Test, Blood Test, H. Pylori Test, Calprotectin Test, Immunoglobulin Test, Other Gastrointestinal Diagnostics Tests); Technology (ELISA Technology, PCR Technology, Microbiology Technology, Other Technologies); Test Location (Central Laboratories Test Location, Point-of-Care Test Location); Application (Infection, Inflammatory Bowel Disease Application, Gastroesophageal Reflux Disease Application, Cancer Application, Other Applications).
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Endoscopy Test segment, which is expected to reach US$1.6 Billion by 2030 with a CAGR of a 2.2%. The Blood Test segment is also set to grow at 1.9% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, valued at $1.3 Billion in 2024, and China, forecasted to grow at an impressive 5.1% CAGR to reach $1.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
- Comprehensive Market Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Abbott Laboratories, AngioDynamics, Boston Scientific Corporation, BTG International Ltd., CONMED Corporation and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 34 companies featured in this Gastrointestinal Diagnostics market report include:
- Abbott Point of Care, Inc.
- Beckman Coulter, Inc.
- bioMerieux SA
- Boston Scientific Corporation
- DiaSorin S.p.A.
- Exact Sciences Corporation
- F. Hoffmann-La Roche Ltd.
- FUJIFILM Holdings Corporation
- Genova Diagnostics, Inc.
- Guardant Health, Inc.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 478 |
| Forecast Period | 2024-2030 |
| Estimated Market Value (USD) in 2024 | $4.9 Billion |
| Forecasted Market Value (USD) by 2030 | $5.8 Billion |
| Compound Annual Growth Rate | 2.8% |
| Regions Covered | Global |
MARKET OVERVIEW
- Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
- How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind
- Gastrointestinal Diagnostics – Global Key Competitors Percentage Market Share in 2025 (E)
- Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
MARKET TRENDS & DRIVERS
- Increasing Global Burden of GI Diseases Drives Demand for Early and Accurate Diagnostic Tools
- Rising Adoption of Non-Invasive and Minimally Invasive GI Diagnostics Spurs Market Growth
- Advancements in Endoscopic Imaging Technologies Enhance Detection of Pre-Cancerous and Inflammatory Conditions
- Surge in Colon Cancer Screening Programs Worldwide Expands Market for Colonoscopy and Sigmoidoscopy Devices
- Integration of AI and Machine Learning in GI Imaging Tools Improves Diagnostic Accuracy and Workflow
- Growing Geriatric Population Elevates Demand for Diagnostics in Age-Related GI Conditions
- Rising Prevalence of Functional GI Disorders Like IBS and IBD Boosts Demand for Advanced Imaging and Lab Tests
- Adoption of Capsule Endoscopy and Wireless Motility Devices Expands Accessibility in Non-Hospital Settings
- Pharmaceutical Companies Collaborating with Diagnostic Firms to Improve GI Disease Stratification and Monitoring
- Increased Consumer Awareness of Digestive Health Drives Demand for Early Symptom Screening
- Expansion of Diagnostic Labs and Gastro Clinics in Emerging Markets Improves Test Accessibility
- Government-Led Health Screenings and CRC Programs Strengthen Institutional Demand for GI Diagnostics
- Rising Use of Biomarkers and Molecular Testing in GI Disease Diagnosis Enhances Clinical Precision
- OEM Innovation in Disposable Scopes and AI-Guided Colonoscopy Enhances Efficiency and Reduces Risk
For more information about this report visit https://www.researchandmarkets.com/r/z2oky7
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Opportunità di mercato
Valore SURGE (SURGE)
$0.01547
$0.01547$0.01547
USD
Grafico dei prezzi in tempo reale di SURGE (SURGE)
Disclaimer: gli articoli ripubblicati su questo sito provengono da piattaforme pubbliche e sono forniti esclusivamente a scopo informativo. Non riflettono necessariamente le opinioni di MEXC. Tutti i diritti rimangono agli autori originali. Se ritieni che un contenuto violi i diritti di terze parti, contatta crypto.news@mexc.com per la rimozione. MEXC non fornisce alcuna garanzia in merito all'accuratezza, completezza o tempestività del contenuto e non è responsabile per eventuali azioni intraprese sulla base delle informazioni fornite. Il contenuto non costituisce consulenza finanziaria, legale o professionale di altro tipo, né deve essere considerato una raccomandazione o un'approvazione da parte di MEXC.
Potrebbe anche piacerti
China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise
The post China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise appeared on BitcoinEthereumNews.com. China Blocks Nvidia’s RTX Pro 6000D as Local Chips Rise China’s internet regulator has ordered the country’s biggest technology firms, including Alibaba and ByteDance, to stop purchasing Nvidia’s RTX Pro 6000D GPUs. According to the Financial Times, the move shuts down the last major channel for mass supplies of American chips to the Chinese market. Why Beijing Halted Nvidia Purchases Chinese companies had planned to buy tens of thousands of RTX Pro 6000D accelerators and had already begun testing them in servers. But regulators intervened, halting the purchases and signaling stricter controls than earlier measures placed on Nvidia’s H20 chip. Image: Nvidia An audit compared Huawei and Cambricon processors, along with chips developed by Alibaba and Baidu, against Nvidia’s export-approved products. Regulators concluded that Chinese chips had reached performance levels comparable to the restricted U.S. models. This assessment pushed authorities to advise firms to rely more heavily on domestic processors, further tightening Nvidia’s already limited position in China. China’s Drive Toward Tech Independence The decision highlights Beijing’s focus on import substitution — developing self-sufficient chip production to reduce reliance on U.S. supplies. “The signal is now clear: all attention is focused on building a domestic ecosystem,” said a representative of a leading Chinese tech company. Nvidia had unveiled the RTX Pro 6000D in July 2025 during CEO Jensen Huang’s visit to Beijing, in an attempt to keep a foothold in China after Washington restricted exports of its most advanced chips. But momentum is shifting. Industry sources told the Financial Times that Chinese manufacturers plan to triple AI chip production next year to meet growing demand. They believe “domestic supply will now be sufficient without Nvidia.” What It Means for the Future With Huawei, Cambricon, Alibaba, and Baidu stepping up, China is positioning itself for long-term technological independence. Nvidia, meanwhile, faces…
Condividi
BitcoinEthereumNews2025/09/18 01:37
Aave DAO to Shut Down 50% of L2s While Doubling Down on GHO
The post Aave DAO to Shut Down 50% of L2s While Doubling Down on GHO appeared on BitcoinEthereumNews.com. Aave DAO is gearing up for a significant overhaul by shutting down over 50% of underperforming L2 instances. It is also restructuring its governance framework and deploying over $100 million to boost GHO. This could be a pivotal moment that propels Aave back to the forefront of on-chain lending or sparks unprecedented controversy within the DeFi community. Sponsored Sponsored ACI Proposes Shutting Down 50% of L2s The “State of the Union” report by the Aave Chan Initiative (ACI) paints a candid picture. After a turbulent period in the DeFi market and internal challenges, Aave (AAVE) now leads in key metrics: TVL, revenue, market share, and borrowing volume. Aave’s annual revenue of $130 million surpasses the combined cash reserves of its competitors. Tokenomics improvements and the AAVE token buyback program have also contributed to the ecosystem’s growth. Aave global metrics. Source: Aave However, the ACI’s report also highlights several pain points. First, regarding the Layer-2 (L2) strategy. While Aave’s L2 strategy was once a key driver of success, it is no longer fit for purpose. Over half of Aave’s instances on L2s and alt-L1s are not economically viable. Based on year-to-date data, over 86.6% of Aave’s revenue comes from the mainnet, indicating that everything else is a side quest. On this basis, ACI proposes closing underperforming networks. The DAO should invest in key networks with significant differentiators. Second, ACI is pushing for a complete overhaul of the “friendly fork” framework, as most have been unimpressive regarding TVL and revenue. In some cases, attackers have exploited them to Aave’s detriment, as seen with Spark. Sponsored Sponsored “The friendly fork model had a good intention but bad execution where the DAO was too friendly towards these forks, allowing the DAO only little upside,” the report states. Third, the instance model, once a smart…
Condividi
BitcoinEthereumNews2025/09/18 02:28
New Crypto Investors Are Backing Layer Brett Over Dogecoin After Topping The Meme Coin Charts This Month
Climbing to the top of the meme coin charts takes more than a viral mascot or celebrity tweets. Hype may spark attention, but only momentum, utility, and adaptability keep it alive. That’s why the latest debate among crypto enthusiasts is catching attention. While Dogecoin remains a household name, a new player has entered the arena […] The post New Crypto Investors Are Backing Layer Brett Over Dogecoin After Topping The Meme Coin Charts This Month appeared first on Live Bitcoin News.
Condividi
LiveBitcoinNews2025/09/18 00:30
